HomeHLUN-A • CPH
add
H Lundbeck A/S Class A
Nakaraang pagsara
kr 35.00
Sakop ng araw
kr 34.50 - kr 35.60
Sakop ng taon
kr 23.30 - kr 39.90
Market cap
42.37B DKK
Average na Volume
87.76K
P/E ratio
-
Dividend yield
-
Primary exchange
CPH
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (DKK) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 6.09B | 9.96% |
Gastos sa pagpapatakbo | 4.36B | 12.55% |
Net na kita | -27.00M | -104.58% |
Net profit margin | -0.44 | -104.13% |
Kita sa bawat share | 0.94 | -30.88% |
EBITDA | 956.00M | -2.65% |
Aktuwal na % ng binabayarang buwis | 107.50% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (DKK) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 3.43B | -26.39% |
Kabuuang asset | 52.05B | -9.72% |
Kabuuang sagutin | 27.15B | -16.84% |
Kabuuang equity | 24.90B | — |
Natitirang share | 991.23M | — |
Presyo para makapag-book | 1.39 | — |
Return on assets | 2.33% | — |
Return on capital | 3.31% | — |
Cash Flow
Net change in cash
| (DKK) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -27.00M | -104.58% |
Cash mula sa mga operasyon | 921.00M | 179.81% |
Cash mula sa pag-invest | -202.00M | 98.65% |
Cash mula sa financing | -765.00M | -106.15% |
Net change in cash | -46.00M | 98.74% |
Malayang cash flow | 944.38M | -46.59% |
Tungkol
H. Lundbeck A/S, commonly referred to as Lundbeck, is a Danish international pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at brain diseases, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease and migraine. Wikipedia
Itinatag
Ago 14, 1915
Website
Mga Empleyado
5,039
